Shire to test its ADHD drug in 4 to 5-year olds in U.S.

Shire Plc has agreed to a U.S. Food and Drug Administration request to study its stimulant Vyvanse in preschool children as concern rises over the diagnosis and treatment of attention deficit hyperactivity disorder, the drugmker said on Thursday. A report last year by the Centers for Disease Control and Prevention found that the number of children diagnosed with ADHD increased 41 percent from …

from Content Keyword RSS http://ift.tt/1qCxhx8 http://ift.tt/eA8V8J

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s